cv9y6nl | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/0cv9y6nl_hasAnnotation_C0023779>
?:creator	<https://research.tib.eu/covid-19/entity/Yadav%2C_Monika%3B_Schiavone%2C_Nicola%3B_Guzman-Aranguez%2C_Ana%3B_Giansanti%2C_Fabrizio%3B_Papucci%2C_Laura%3B_Perez_de_Lara%2C_Maria_J.%3B_Singh%2C_Mandeep%3B_Kaur%2C_Indu_Pal>
?:doi	<https://research.tib.eu/covid-19/entity/10.1007/s13346-020-00777-6>
?:doi	10.1007/s13346-020-00777-6
?:externalLink	<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608326/>
?:journal	Drug_Deliv_Transl_Res
?:license	no-cc
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7608326>
?:pmid	<https://research.tib.eu/covid-19/entity/32363537>
?:pmid	32363537
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:source	PMC
?:title	Correction to: Atorvastatin-loaded solid lipid nanoparticles as eye drops: proposed treatment option for age-related macular degeneration (AMD)
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-05-03

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/0cv9y6nl>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/0cv9y6nl>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all